Reducing cholesterol to very low levels by treating high risk patients with a statin as well as a proprotein convertase subtilisin-kexin type 9 (PSCK9) inhibitor is associated with a 20% reduction in...
from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2xJXFi8
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,